PodcastRx with Chris Bender - June 2026

Topic

News

How can healthcare providers deal with drug shortages?

Listen here or wherever you enjoy podcasts!

Drug shortages aren’t just temporary supply hiccups—they can become full-blown healthcare crises that can last for years and directly impact patient outcomes (especially in correctional settings). We look at all the dimensions of drug shortages, from manufacturing failures and fragile supply chains to economic and regulatory challenges. Chris highlights notable examples such as heparin and norepinephrine, examines the unique risks that shortages pose in correctional healthcare, and shares practical strategies that providers can use to prepare, respond, and protect patients when critical medications become scarce.

Sponsor Links:

www.opticsclinical.com

www.sapphire-health.com

Music in this Episode:

The Retro Synth by Art Haiz

Vitals & Headlines (Suno AI)

Breezy Thoughts (Suno AI)

Trivia Time Ticker (Suno AI)

References/Further Reading:

Into the Clinic:

1. Foundayo (orforglipron) — FDA approves first oral non-peptide GLP-1 receptor agonist for chronic weight management. FDA News Release. April 1, 2026. https://www.fda.gov/drugs/new-drugs-fda-cder-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2026

2. Awiqli (insulin icodec) — FDA approves once-weekly basal insulin for type 2 diabetes. FDA News Release. March 26, 2026.

3. Generic Dapagliflozin — FDA approves first generics of Farxiga. FDA News Release. April 7, 2026. https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-first-generics-farxiga

4. Mirtazapine for Methamphetamine Use Disorder — McKetin R, et al. Mirtazapine for methamphetamine use disorder: a randomized clinical trial. JAMA Psychiatry. Published online April 1, 2026 doi:10.1001/jamapsychiatry.2026.0159

Drug Shortages:

5. FDA Drug Shortages FAQ — U.S. FDA. Drug Shortages: Frequently Asked Questions. https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages

6. FDA Report to Congress — U.S. FDA. Report to Congress: Drug Shortages for Calendar Year 2020. FDA; 2021.

7. ASPE/HHS Analysis— ASPE/HHS. Analysis of Drug Shortages 2018–2023. Washington, DC: HHS; January 2025. https://aspe.hhs.gov

8. Mental Health in Corrections — Bronson J, Berzofsky M. Indicators of Mental Health Problems Reported by Prisoners and Jail Inmates,2011–12. BJS Special Report NCJ 250612. Washington, DC: BJS; 2017. https://bjs.ojp.gov

9. ASHP Drug Shortage Statistics — ASHP. Drug Shortage Statistics Q1 2024. Bethesda, MD: ASHP; 2024. https://www.ashp.org/drug-shortages

10. GAO Report — U.S. GAO. Drug Shortages: HHS Should Implement a Mechanism to Coordinate Its Activities. GAO-25-107110. Washington, DC: GAO;2024. https://www.gao.gov/products/gao-25-107110

11. Heparin Shortage Database — U.S. FDA. Drug Shortage Database: Heparin Sodium Injection [continuously updated]. https://accessdata.fda.gov/scripts/drugshortages

12. Drug Shortages Review — McLaughlin M, et al. Drug shortages in US health systems: review of causes and policy responses. Am JHealth Syst Pharm. 2013;70(15):1351–1361. doi:10.2146/ajhp120563

13. Norepinephrine Shortage & Mortality — Vail E, et al. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock. JAMA. 2017;317(14):1433–1442. doi:10.1001/jama.2017.2841

14. FDA Safety and Innovation Act — Drug Safety and Innovation Act (FDASIA), Public Law 112-144, Section 1001. Washington, DC;2012.

15. Vizient Cost Survey — Vizient, Inc. Beyond the Shortage: The Hidden Cost of Drug Supply Chain Disruptions. Irving, TX: Vizient; June 2025. https://www.vizientinc.com/newsroom

16. Estelle v. Gamble — Estelle v. Gamble, 429 U.S.97 (1976). United States Supreme Court.

17. Buprenorphine Bioavailability — Moody DE, et al. Buprenorphine and naloxone bioavailability after buccal, sublingual, and sublabial administration. Clin Pharmacokinet. 2022;61(11):1621–1630.doi:10.1007/s40262-022-01163-4

18. ASHP Shortage Management Guidelines — ASHP. Guidelines on Managing Drug Product Shortages. Am J Health Syst Pharm. 2018;75(21):1742–1750. doi:10.2146/ajhp180441

19. FDA Med Watch Reporting — U.S. FDA. MedWatch: FDA Safety Information and Adverse Event Reporting Program. https://www.fda.gov/safety/report-a-problem

Trivia Capsule:

20. Cinchona /Quinine History — Gachelin G, et al. Evaluating cinchona bark and quinine for treating and preventing malaria. J RSoc Med. 2017;110(1):31–40. doi:10.1177/0141076816681421

21. Quinine Modern Role — Achan J, et al. Quinine, an old anti-malarial drug in a modern world. Malar J. 2011;10:144.doi:10.1186/1475-2875-10-144

22. Cinchona History(Cambridge) — Rocco A. Cinchona: a short history. Cambridge University Library. https://www.lib.cam.ac.uk/rcs/projects-exhibitions/products-empire-cinchona-short-history

23. Quinine Global History — Cassauwers T. The global history of quinine, the world's first anti-malaria drug. Medium. https://medium.com/@tcassauwers/the-global-history-of-the-worlds-first-anti-malaria-drug-d1e11f0ba729